Search results
Results from the WOW.Com Content Network
Researchers developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss. The new microneedle patch delivers immune-regulating molecules that can teach T cells not to attack hair follicles, helping hair regrow.
Researchers have developed a novel treatment to reverse hair loss caused by the autoimmune disease alopecia areata, using a microneedle patch to painlessly target affected areas of the skin. Alopecia areata causes hair loss when T cells mistakenly attack follicles.
Just a year after the U.S. Food and Drug Administration (FDA) approved the first treatment for severe alopecia areata, the federal agency has approved a second treatment for the disfiguring skin disease — both the result of pioneering research by the same Yale dermatologist.
Each day, researchers smeared a small dose of deoxyribose sugar gel on the exposed skin, and within weeks, the fur in this region showed 'robust' regrowth, sprouting long, thick individual hairs.
A signaling molecule known as SCUBE3, which was discovered by researchers at the University of California, Irvine, has the potential to cure androgenetic alopecia, a prevalent type of hair loss in both women and men.
The process by which aged, or senescent, pigment-making cells in the skin cause significant growth of hair inside skin moles, called nevi, has been identified by a research team led by the University of California, Irvine.
A single molecule may hold the key to battling male- and female-pattern hair loss, recent research suggests. In mouse experiments, scientists showed that the molecule, dubbed SCUBE3, could...